catechin has been researched along with Prostatic Neoplasms in 148 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (2.70) | 18.2507 |
| 2000's | 74 (50.00) | 29.6817 |
| 2010's | 58 (39.19) | 24.3611 |
| 2020's | 12 (8.11) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Guo, Y; Hao, Z; Peng, Y; Sun, L; Wang, T; Wu, Z; Xu, C; Zhang, Z; Zhao, S; Zheng, F | 1 |
| Cao, J; Chen, R; Lai, X; Li, Q; Sun, L; Sun, S; Wen, S; Zhang, Z | 1 |
| Carastro, LM; Cordova, R; Costello, CM; Declet-Bauzo, RA; Gannon, AN; Kim, SJ; Kumar, N; Park, JY; Vallebuona, EJ | 1 |
| Magri, V; Perletti, G; Stamatiou, K; Trinchieri, A; Vral, A | 1 |
| Levonis, SM; Schweiker, SS; Tauber, AL | 1 |
| Han, DS; Lee, EO; Lee, HJ; Yeo, C | 1 |
| Burlando, B; Gavazzo, P; Marchetti, C | 1 |
| Bogdanos, DP; Gkiouras, K; Goulis, DG; Grammatikopoulou, MG; Mykoniatis, I; Myrogiannis, I; Papageorgiou, SΤ; Papamitsou, T | 1 |
| Chen, ML; Huang, CM; Lai, CJ; Lin, YH; Lin, YN | 1 |
| Abediankenari, S; Jafari, N; Mahrooz, A; Mardomi, A; Mokhtari, H; Sirati-Sabet, M; Yaghmaei, B | 1 |
| Dong, J; Thomas, P | 1 |
| Chen, BH; Lin, YH; Wang, CC | 1 |
| Boso, S; Freire-Garabal, M; Gago, P; García, C; Martínez, MC; Novio, S; Núñez-Iglesias, MJ; Pérez-Muñuzuri, ME; Santiago, JL | 1 |
| Chen, P; Guo, Y; Mao, Q; Wang, X; Xiang, H; Zhang, X; Zhao, K; Zhi, F | 1 |
| He, YH; Ho, WM; Kan, HD; Lee, MK; Lee, PMY; Liu, ZM; Ng, CF; Ng, SSM; Tse, LA; Wang, F; Wong, SYS | 1 |
| Carru, C; Cossu, A; Fois, M; Giordo, R; Phu, HT; Piga, A; Pintus, G; Posadino, AM; Sotgia, S; Thuan, DTB; Zinellu, A | 1 |
| Bianchi, G; Ferrari, N; Martorana, E; Micali, S; Navarra, M; Pirola, GM; Sighinolfi, MC; Territo, A | 1 |
| Bimonte, S; Boccellino, M; Botti, G; Capunzo, M; Caraglia, M; Ciliberto, G; Crispo, A; D'Arena, G; Facchini, G; Giudice, A; Montella, M; Quagliuolo, L | 1 |
| Gründemann, C; Hattori, F; Huber, R; Klemd, A; Ohmori, K; Stadlbauer, S; Steinborn, C; Suzuki, K; Wolf, P | 1 |
| Chen, L; Chen, W; Liu, R; Lu, Q; Yan, F; Zhang, J; Zhao, L | 1 |
| Eisenstein, M | 1 |
| Karpov, EI | 1 |
| Agarwal, C; Agarwal, R; Kumar, S; Maroni, PD; Raina, K; Tyagi, A; Wempe, MF | 1 |
| Bodner, DR; Deb, G; Fu, P; Gupta, S; Ponsky, LE; Shankar, E; Thakur, VS | 1 |
| Popov, SV; Rogovskii, VS; Shimanovskii, NL; Sturov, NV | 1 |
| Chu, PY; Ko, HY; Lin, YH; Tsai, SC; Wu, CC | 1 |
| Bowler, E; Chedea, VS; Hagen, RM; Ladomery, MR; Mintoff, CP; Morse, HR | 1 |
| Chen, D; Ling, C; Miao, A; Pan, S; Pang, S; Sun, S; Tang, J; Zhao, C | 1 |
| Arts, IC; Geybels, MS; Goldbohm, RA; van den Brandt, PA; van Schooten, FJ; Verhage, BA | 1 |
| Fujii, H; Hattori, Y; Katoh, M; Kawaguchi, K; Kawahara, S; Makabe, H; Matsumoto, K; Suda, M; Toda, K | 1 |
| Adhami, VM; Bharali, DJ; Cui, H; Khan, N; Mousa, SA; Mukhtar, H; Shabana, SM; Siddiqui, IA | 1 |
| Amankwah, E; Choi, J; Chornokur, G; Connors, S; Cornnell, H; Engelman, RW; Hashim, AI; Kim, SJ; Kumar, N; Park, HY; Park, JY; Rincon, M; Tsai, YY | 1 |
| Cheon, GJ; Eom, DW; Ham, J; Hwang, GS; Jang, HJ; Kang, KS; Kim, KH; Kim, SN; Kim, YJ; Kwak, JH; Lee, JH; Yamabe, N | 1 |
| Chang, PL; Chen, WT; Chung, LC; Feng, TH; Juang, HH; Lee, TY; Tsui, KH | 1 |
| Gasiewicz, TA; Henry, EC; Moses, MA; Ricke, WA | 1 |
| Heber, D; Henning, SM; Vadgama, JV; Wang, P | 1 |
| Chornokur, G; Crocker, T; Diaz, K; Dickinson, S; Egan, KM; Helal, M; Kang, L; Kazi, A; Kumar, NB; McLarty, J; Parnes, HL; Pow-Sang, J; Quinn, G; Salup, R; Schell, MJ; Schreiber, F; Sebti, S; Smith, T; Spiess, PE; Williams, CR; Yue, B | 1 |
| Castro Nava, A; Cirillo, G; Cojoc, M; Dubrovska, A; Erdmann, K; Fuessel, S; Hampel, S; Kunhardt, D; Kurth, I; Peitzsch, C; Vittorio, O | 1 |
| Abu Osman, NA; Asadi-Eydivand, M; Kalantarinejad, R; Samadikuchaksaraei, A; Shafiei, SS; Solati-Hashjin, M | 1 |
| Bettuzzi, S; Bonacini, M; Giovanna Troglio, M; Modernelli, A; Naponelli, V; Ramazzina, I; Rizzi, F | 1 |
| Chen, BH; Tsai, YJ | 1 |
| Kumar, NB; Park, J; Parnes, H; Pow-Sang, J; Salup, R; Schell, MJ; Spiess, PE; Williams, CR | 1 |
| Adhami, VM; Chamcheu, JC; Jashari, R; Mukhtar, H; Rady, I; Sanna, V; Sechi, M; Siddiqui, IA; Singh, CK | 1 |
| Bettuzzi, S; Caporali, A; Corti, A; Davalli, P; Enkemann, S; Eschrich, S; Lee, A; McCarthy, S; Scaltriti, M; Sung, J; Yeatman, TJ | 1 |
| Chan, TH; Chan, WK; Lam, WH; Lee, SC; Lee, TW; Wang, X; Wong, YC | 1 |
| Bahl, A; Holly, JM; Patel, S; Perks, CM; Persad, R; Thomas, F | 1 |
| Chen, RY; Chuu, CP; Hiipakka, RA; Kokontis, JM; Liao, S | 1 |
| He, GQ; Shen, SR; Sun, SL; Yang, JG; Yu, HN; Zhang, LC | 1 |
| Das, UN; He, G; Ruan, H; Shen, S; Sun, S; Yang, J; Yu, H; Zhang, L | 1 |
| Gupta, S; Pandey, M | 1 |
| Das, UN; He, GQ; Ruan, H; Shen, SR; Sun, SL; Yang, JG; Yu, HN; Zhang, LC | 1 |
| Das, UN; Shen, SR; Yang, JG; Yu, HN; Zhang, LC | 1 |
| Jiang, R; Yuan, S; Zhang, XN; Zhang, Y; Zhao, XH; Zu, YG | 1 |
| Hsieh, TC; Wu, JM | 1 |
| Bettuzzi, S; Rizzi, F | 2 |
| Adhami, VM; Khan, N; Mukhtar, H | 2 |
| Bailey, HH; Johnson, JJ; Mukhtar, H | 1 |
| Luo, JH; Luo, KL; Yu, YP | 1 |
| Agarwal, C; Agarwal, R; Chou, SC; Kaur, M; Thompson, JA | 1 |
| Bigelow, RL; Cardelli, JA; Coleman, DT; Duhon, D; Kevil, CG; Langston, W; Steffan, JJ; Yu, C | 1 |
| Barve, A; Cai, L; Chan, JY; Khor, TO; Kong, AN; Lin, W; Nair, S; Shen, GX | 1 |
| Bhattacharyyal, K; Boote, E; Dale, PS; Goldschmidt, BS; Gupta, S; Kannan, R; Katti, K; Shukla, R; Viator, JA | 1 |
| Bray, TM; Bruno, RS; Dashwood, RH; Ho, E; Hsu, A; Löhr, CV; Taylor, AW | 1 |
| Choi, KC; Lee, YH; Lim, BJ; Na, Y; Naito, S; Park, S; Seong, AR; Shiota, M; Sung, AR; Yokomizo, A; Yoon, HG | 1 |
| Amatangelo, MD; Goodyear, SM; Sell, C; Stearns, ME; Varma, D | 1 |
| Adhami, VM; Asim, M; Hafeez, BB; Mukhtar, H; Siddiqui, IA; Tarapore, RS | 1 |
| Coelho, MA; Generalov, R; Juzenas, P; Pereira, Mdo C; Peres, I; Rocha, S | 1 |
| Arca, A; Bandiera, P; Marceddu, S; Pintus, G; Posadino, AM; Punzoni, S; Roggio, AM; Sanna, V; Sechi, M; Uzzau, S | 1 |
| Bannerman, B; Berger, A; Bolen, J; Claiborne, C; Dick, L; Fleming, P; Hales, P; Jones, M; Kupperman, E; Manfredi, M; Monbaliu, J; Tsu, C; Xu, L; Yu, J | 1 |
| Bahl, A; Holly, JM; Perks, CM; Persad, R; Thomas, F | 1 |
| Arcari, M; Astancolle, S; Azzali, G; Bettuzzi, S; Caldara, GF; Corti, A; Davalli, P; Davoli, S; Rizzi, F; Silva, A; Vitale, M | 1 |
| Ahmann, FR; Chow, HH; Gretzer, MB; Hsu, CH; Nagle, RB; Nguyen, MM; Parnes, HL; Sokoloff, MH; Tangrea, JA | 1 |
| Ahsan, Qu; Asif, H; Bhatti, S; Dilawar, BA; Farooqi, AA; Fayyaz, S; Javed, Z; Javeed, MK; Khanum, R; Mansoor, Q; Nisar, K; Rana, A; Riaz, AM | 1 |
| Chornokur, G; Connors, SK; Kumar, NB | 1 |
| Heber, D; Henning, SM; Wang, P | 1 |
| Choi, HK; Choi, KC; Jun, W; Kim, S; Kwak, J; Lee, J; Lee, YH; Park, HJ; Yoon, HG | 1 |
| Gupta, K; Gupta, S; Thakur, VS | 1 |
| Castelli, T; Cimino, S; Favilla, V; Madonia, M; Morgia, G; Russo, GI; Sansalone, S; Sortino, G | 1 |
| Boote, E; Caldwell, C; Carmack, TL; Casteel, SW; Chanda, N; Cutler, CS; Engelbrecht, H; Kan, P; Kannan, R; Katti, K; Katti, KV; Kulkarni, RR; Lever, JR; Nune, SK; Robertson, JD; Shukla, R; Smith, CJ; Upendran, A; Vimal, J; Watkinson, LD; Zambre, A | 1 |
| Bhaskaran, N; Fu, P; Gupta, S; Kanwal, R; Maclennan, GT; Pandey, M; Ponsky, LE | 1 |
| Abgaryan, N; Aronson, WJ; Carpenter, CL; de Oliveira, DM; Heber, D; Henning, SM; Lee, RP; Vicinanza, R; Wang, P; Zhang, Y | 1 |
| Gupta, S; Mukhtar, H | 1 |
| Mukhtar, H; Wang, SI | 1 |
| Dou, QP; Kazi, A; Smith, DM; Zhong, Q | 1 |
| Gupta, S; Hussain, T; Mukhtar, H | 1 |
| Blackburn, GL; Yu, L; Zhong, Y; Zhou, JR | 1 |
| Adhami, VM; Ahmad, N; Mukhtar, H | 1 |
| Agarwal, MK; Agarwal, ML; Ahmad, N; Gupta, S; Hastak, K; Mukhtar, H | 1 |
| Brusselmans, K; De Schrijver, E; Heyns, W; Swinnen, JV; Verhoeven, G | 1 |
| Afaq, F; Ahmad, N; Gupta, S; Hastak, K; Mukhtar, H | 1 |
| Adhami, VM; Afaq, F; Ahmad, N; Mukhtar, H; Siddiqui, IA | 1 |
| Shen, SR; Yin, JJ; Yu, HN | 3 |
| Ho, CT; Lee, HH; Lin, JK | 1 |
| Katiyar, SK; Vayalil, PK | 1 |
| Astancolle, S; Bettuzzi, S; Brausi, M; Caporali, A; Corti, A; D'Arca, D; Davalli, P | 1 |
| Albini, A; Calabrese, F; Dell'Aica, I; Donà, M; Garbisa, S; Morini, M; Pezzato, E; Sartor, L | 1 |
| Belluco, C; Dell'Aica, I; Dittadi, R; Garbisa, S; Gion, M; Lise, M; Pezzato, E; Sartor, L | 1 |
| Adhami, VM; Gupta, S; Hussain, T; Mukhtar, H | 1 |
| Ansell, PJ; Browning, JD; Lubahn, DB; Macdonald, RS; Sakla, MS; Shenouda, NS; Zhou, C | 1 |
| Shen, SR; Xiong, YK; Yu, HN | 1 |
| Agarwal, MK; Agarwal, ML; Hastak, K; Mukhtar, H | 1 |
| Axanova, L; Morré, DJ; Morré, DM | 1 |
| Kim, MH; Thomas, R | 1 |
| Cooper, R; Morré, DJ; Morré, DM | 1 |
| Chuang, JC; Jones, PA; Kwan, JM; Li, TW; Liang, G; Yang, AS; Yoo, CB | 1 |
| Astancolle, S; Belloni, L; Bettuzzi, S; Caporali, A; Corti, A; Davalli, P; Remondini, D; Rizzi, F; Scaltriti, M | 1 |
| Adhami, VM; Ahmad, N; Aziz, MH; Mukhtar, H; Raisuddin, S; Reagan-Shaw, SR; Sarfaraz, S; Siddiqui, IA; Zaman, N | 1 |
| Bettuzzi, S; Brausi, M; Castagnetti, G; Corti, A; Peracchia, G; Rizzi, F | 1 |
| Adhami, VM; Mukhtar, H; Saleem, M; Siddiqui, IA | 1 |
| Wu, AH; Yu, MC | 1 |
| Bemis, DL; Buttyan, R; Capodice, JL; Costello, JE; Katz, AE; Vorys, GC | 1 |
| Aronson, W; Barnard, RJ; Conde, F; Csathy, G; Go, VL; Harris, DM; Heber, D; Henning, SM; Hong, J; Lee, NH; Lee, RP; Lu, J; Moro, A; Niu, Y; Pak-Shan, L; Seeram, NP; Wang, H; Ziaee, HG | 1 |
| Benghuzzi, H; Hughes, J; Jones, P; Richards, LR; Tucci, M | 2 |
| Rosengren, RJ; Scandlyn, MJ; Stuart, EC | 1 |
| Ling, MT; Wang, X; Wong, YC; Zhang, X | 1 |
| Friedman, M; Kim, HJ; Kozukue, E; Kozukue, N; Lee, IS; Lee, KR; Lee, SU; Mackey, BE | 1 |
| Ahmad, KA; Ahmed, K; Harris, NH; Johnson, AD; Lindvall, HC; Wang, G | 1 |
| Belloni, L; Bettuzzi, S; Rizzi, F | 1 |
| Chen, X; Shen, S; Yin, J; Yu, H | 1 |
| Kalra, N; Pant, AB; Prasad, S; Seth, K; Shukla, Y; Singh, M | 1 |
| Ivanov, V; Kalinovsky, T; Niedzwiecki, A; Rath, M; Roomi, MW | 1 |
| Eltoum, IA; Harper, CE; Lamartiniere, CA; Patel, BB; Wang, J | 1 |
| Albrecht, DS; Bomser, JA; Clubbs, EA; Ferruzzi, M | 1 |
| Kalra, N; Kaur, J; Prasad, S; Roy, P; Shukla, Y | 1 |
| Adhami, VM; Asim, M; Hafeez, BB; Malik, A; Mukhtar, H; Sarfaraz, S; Siddiqui, IA | 1 |
| Borthakur, D; Das, UN; He, GQ; Shen, SR; Sun, SL; Yang, JG; Yu, HN; Zhang, LC | 1 |
| Kim, MH | 1 |
| He, GQ; Ruan, H; Shen, SR; Sun, SL; Yang, JG; Yu, HN; Zhang, LC | 1 |
| Bettuzzi, S; Brausi, M; Rizzi, F | 1 |
| Actis-Goretta, L; Keen, CL; Kwik-Uribe, C; Rodriguez, CA; Romanczyk, LJ | 1 |
| Weinstein, B | 1 |
| Guo, J; Hiipakka, RA; Kokontis, JM; Liao, S; Umekita, Y | 1 |
| Butler, R; Paschka, AG; Young, CY | 1 |
| Ahmad, N; Gupta, S; Mukhtar, H | 1 |
| Ahmad, N; Gupta, S; Mukhtar, H; Nieminen, AL | 1 |
| Sakamoto, K | 1 |
| Butler, R; Mitchell, SH; Ren, F; Young, CY; Zhang, S | 1 |
| Agarwal, R | 1 |
| Agarwal, R; Bhatia, N | 1 |
| Chan, ZY; Cheung, TC; Choy, YM; Chung, LY; Fung, KP; Kong, SK; Kwok, TT | 1 |
| Dou, QP; Nam, S; Smith, DM | 1 |
| Liao, S | 1 |
26 review(s) available for catechin and Prostatic Neoplasms
| Article | Year |
|---|---|
Green tea catechins for chemoprevention of prostate cancer in patients with histologically-proven HG-PIN or ASAP. Concise review and meta-analysis.
Topics: Catechin; Chemoprevention; Humans; Male; Neoplasm Grading; Plant Extracts; Prostate; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Tea | 2019 |
From tea to treatment; epigallocatechin gallate and its potential involvement in minimizing the metabolic changes in cancer.
Topics: Camellia sinensis; Catechin; Humans; Male; Phosphoinositide-3 Kinase Inhibitors; Plant Leaves; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Signal Transduction; Tea; TOR Serine-Threonine Kinases | 2020 |
Dietary Factors and Supplements Influencing Prostate Specific-Antigen (PSA) Concentrations in Men with Prostate Cancer and Increased Cancer Risk: An Evidence Analysis Review Based on Randomized Controlled Trials.
Topics: Adult; Aged; Antioxidants; Catechin; Diet; Dietary Supplements; Humans; Male; Middle Aged; Phytoestrogens; Phytotherapy; Prostate-Specific Antigen; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Risk Factors; Treatment Outcome; Vitamins | 2020 |
Green tea and the risk of prostate cancer: A systematic review and meta-analysis.
Topics: Carcinoma; Catechin; Humans; Male; Phytotherapy; Prostatic Neoplasms; Tea | 2017 |
Epigenetic Changes Induced by Green Tea Catechins a re Associated with Prostate Cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Catechin; Drug Synergism; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Male; Prostatic Neoplasms; Tea | 2017 |
The Possibility of Preventive and Therapeutic Use of Green Tea Catechins in Prostate Cancer.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Catechin; Humans; Male; Plant Extracts; Polyphenols; Prostatic Neoplasms; Tea; Tumor Microenvironment | 2019 |
Green tea and prostate cancer: from bench to clinic.
Topics: Animals; Anticarcinogenic Agents; Camellia sinensis; Catechin; Humans; Male; Mice; Phytotherapy; Plant Extracts; Prostatic Neoplasms; Signal Transduction | 2009 |
Clusterin (CLU) and prostate cancer.
Topics: Animals; Catechin; Cell Line, Transformed; Clusterin; Cyclooxygenase 2 Inhibitors; Genes, Tumor Suppressor; Humans; Male; Neoplasm Metastasis; Prostatic Neoplasms; Signal Transduction | 2009 |
The clusterin paradigm in prostate and breast carcinogenesis.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Apoptosis; Breast Neoplasms; Catechin; Cell Transformation, Neoplastic; Clusterin; Drug Resistance, Neoplasm; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Oncogenes; Orchiectomy; Prostatic Neoplasms; Protein Isoforms; Tumor Suppressor Proteins; Xenograft Model Antitumor Assays | 2010 |
Apoptosis by dietary agents for prevention and treatment of prostate cancer.
Topics: Adenocarcinoma; Aged; Animals; Apoptosis; Carotenoids; Catechin; Clinical Trials as Topic; Curcumin; Drug Screening Assays, Antitumor; Flavonoids; Flavonols; Genistein; Humans; Lycopene; Lythraceae; Male; Mice; Mice, Nude; Mice, Transgenic; Middle Aged; Neoplasm Proteins; Pentacyclic Triterpenes; Phytotherapy; Plant Extracts; Prostatic Neoplasms; Resveratrol; Stilbenes; Tumor Cells, Cultured | 2010 |
Green tea polyphenols for prostate cancer chemoprevention: a translational perspective.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Camellia sinensis; Catechin; Cell Survival; Flavonoids; Humans; Male; Phenols; Phytotherapy; Plant Extracts; Polyphenols; Prostatic Neoplasms; Tea | 2010 |
Review: green tea polyphenols in chemoprevention of prostate cancer: preclinical and clinical studies.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Catechin; Disease Progression; Flavonoids; Humans; Male; Phenols; Polyphenols; Prostatic Neoplasms; Risk Factors; Tea | 2009 |
New insights into the mechanisms of green tea catechins in the chemoprevention of prostate cancer.
Topics: Anticarcinogenic Agents; Apoptosis; Catechin; Cell Cycle Checkpoints; Cell Proliferation; Humans; Male; NF-kappa B; Prostatic Neoplasms; Proteasome Inhibitors; Tea | 2012 |
Polyphenols: key issues involved in chemoprevention of prostate cancer.
Topics: Antioxidants; Catechin; Curcumin; Flavonoids; Genistein; Humans; Male; Polyphenols; Prostatic Neoplasms; Quercetin; Resveratrol; Stilbenes | 2012 |
Molecular targets for green tea in prostate cancer prevention.
Topics: Animals; Antineoplastic Agents; Apoptosis; Catechin; Chemoprevention; Clinical Trials as Topic; Humans; Male; Metalloendopeptidases; Mice; Oligonucleotide Array Sequence Analysis; Prostatic Neoplasms; Tea; Tumor Cells, Cultured | 2003 |
Medicinal benefits of green tea: part II. review of anticancer properties.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Breast Neoplasms; Camellia sinensis; Catechin; Female; Free Radical Scavengers; Humans; Male; Neoplasms; Plant Extracts; Prostatic Neoplasms; Tea | 2005 |
Beneficial effects of tea and its polyphenols against prostate cancer.
Topics: Androgens; Animals; Apoptosis; Catechin; Cell Cycle; Clinical Trials as Topic; Fermentation; Flavonoids; Gene Expression; Humans; Male; Neoplasm Transplantation; Neovascularization, Pathologic; Phenols; Polyamines; Polyphenols; Prostate-Specific Antigen; Prostatic Neoplasms; Signal Transduction; Tea | 2006 |
Tea, hormone-related cancers and endogenous hormone levels.
Topics: Animals; Breast Neoplasms; Catechin; Female; Hormones; Humans; Male; Neoplasms; Ovarian Neoplasms; Prostatic Neoplasms; Risk Factors; Tea | 2006 |
The use of herbal and over-the-counter dietary supplements for the prevention of prostate cancer.
Topics: Anticarcinogenic Agents; Carotenoids; Catechin; Dietary Supplements; Humans; Lycopene; Male; Nonprescription Drugs; Phytotherapy; Plant Preparations; Prostatic Neoplasms | 2006 |
Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancer.
Topics: Anticarcinogenic Agents; Apoptosis; Breast Neoplasms; Catechin; Cell Cycle; Female; Humans; Male; Prostatic Neoplasms; Tea; Urokinase-Type Plasminogen Activator | 2006 |
Clinical relevance of the inhibitory effect of green tea catechins (GtCs) on prostate cancer progression in combination with molecular profiling of catechin-resistant tumors: an integrated view.
Topics: Animals; Catechin; Disease Progression; Drug Resistance, Neoplasm; Humans; Male; Prostatic Neoplasms; Tea | 2007 |
Effects of metal ions, catechins, and their interactions on prostate cancer.
Topics: Animals; Anticarcinogenic Agents; Cadmium; Catechin; Copper; Drug Interactions; Humans; Male; Metals; Prostate; Prostatic Neoplasms; Tea; Zinc | 2007 |
Relevance of the concept of oncogene addiction to hormonal carcinogenesis and molecular targeting in cancer prevention and therapy.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Catechin; Female; Humans; Male; Neoplasms, Hormone-Dependent; Oncogenes; Prostatic Neoplasms; Sulindac | 2008 |
Prostate cancer chemoprevention by green tea.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Catechin; Chemoprevention; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Evidence-Based Medicine; Humans; Male; Phytotherapy; Prostate-Specific Antigen; Prostatic Neoplasms; Risk Factors; Tea | 1999 |
Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents.
Topics: Anticarcinogenic Agents; Antioxidants; Catechin; Cell Cycle; Cell Cycle Proteins; Diet; ErbB Receptors; Genistein; Humans; Male; Prostatic Neoplasms; Protein-Tyrosine Kinases; Signal Transduction; Silymarin | 2000 |
The medicinal action of androgens and green tea epigallocatechin gallate.
Topics: Androgens; Animals; Catechin; Complementary Therapies; Female; Humans; Male; Medicine, East Asian Traditional; Phytotherapy; Plant Extracts; Prostatic Hyperplasia; Prostatic Neoplasms; Sensitivity and Specificity; Tea | 2001 |
8 trial(s) available for catechin and Prostatic Neoplasms
| Article | Year |
|---|---|
Effect of green tea catechins in patients with high-grade prostatic intraepithelial neoplasia: Results of a short-term double-blind placebo controlled phase II clinical trial.
Topics: Aged; Biopsy; Catechin; Double-Blind Method; Follow-Up Studies; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Quality of Life; Tea; Time Factors | 2017 |
Randomized, Placebo-Controlled Trial of Green Tea Catechins for Prostate Cancer Prevention.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Catechin; Disease Progression; Double-Blind Method; Humans; Male; Middle Aged; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Tea | 2015 |
Randomized, placebo-controlled trial evaluating the safety of one-year administration of green tea catechins.
Topics: Aged; Aged, 80 and over; Catechin; Humans; Liver Function Tests; Male; Middle Aged; Placebos; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Tea; Treatment Outcome | 2016 |
Randomized, double-blind, placebo-controlled trial of polyphenon E in prostate cancer patients before prostatectomy: evaluation of potential chemopreventive activities.
Topics: Aged; Biological Availability; Biomarkers, Tumor; Catechin; Double-Blind Method; Humans; Immunoenzyme Techniques; Male; Neoplasm Staging; Prognosis; Prostatectomy; Prostatic Neoplasms; Tea | 2012 |
Phenolic acid concentrations in plasma and urine from men consuming green or black tea and potential chemopreventive properties for colon cancer.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Anticarcinogenic Agents; Antineoplastic Combined Chemotherapy Protocols; Camellia sinensis; Catechin; Cell Proliferation; Chromatography, High Pressure Liquid; Colonic Neoplasms; Gallic Acid; HCT116 Cells; Hippurates; Humans; Hydroxybenzoates; Lactones; Male; Middle Aged; Phenylacetates; Prostatic Neoplasms; Tea | 2013 |
Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study.
Topics: Administration, Oral; Aged; Catechin; Chemoprevention; Double-Blind Method; Humans; Male; Middle Aged; Placebos; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Neoplasms; Quality of Life; Tea | 2006 |
Tea polyphenols and theaflavins are present in prostate tissue of humans and mice after green and black tea consumption.
Topics: Aged; Animals; Anticarcinogenic Agents; Antioxidants; Biflavonoids; Biological Availability; Catechin; Chromatography, High Pressure Liquid; Flavonoids; Humans; Male; Mice; Mice, Inbred C57BL; Middle Aged; Phenols; Polyphenols; Prostate; Prostatic Neoplasms; Tea; Tissue Distribution; Tumor Cells, Cultured | 2006 |
Chemoprevention of human prostate cancer by green tea catechins: two years later. A follow-up update.
Topics: Catechin; Follow-Up Studies; Humans; Male; Prostatic Neoplasms; Tea; Time Factors | 2008 |
114 other study(ies) available for catechin and Prostatic Neoplasms
| Article | Year |
|---|---|
Epicatechin gallate prevents the de novo synthesis of fatty acid and the migration of prostate cancer cells.
Topics: Acetyl-CoA Carboxylase; Animals; Antineoplastic Agents, Phytogenic; ATP Citrate (pro-S)-Lyase; Catechin; Cell Line, Tumor; Cell Movement; Cell Survival; Fatty Acid Synthase, Type I; Fatty Acids; Humans; Lipogenesis; Male; Mice, Inbred BALB C; Mice, Nude; Phosphatidylinositol 3-Kinases; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays | 2021 |
Theaflavin-3,3'-di-gallate represses prostate cancer by activating the PKCδ/aSMase signaling pathway through a 67 kDa laminin receptor.
Topics: Animals; Antioxidants; Biflavonoids; Catechin; Cell Line, Tumor; Humans; Male; Mice; Mice, Inbred NOD; Mice, SCID; Prostatic Neoplasms; Receptors, Laminin; Signal Transduction | 2022 |
Polyphenon E Effects on Gene Expression in PC-3 Prostate Cancer Cells.
Topics: Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Catechin; Gene Expression; Humans; Male; PC-3 Cells; Prostatic Neoplasms; Repressor Proteins | 2022 |
Epigallocatechin-3-Gallate Suppresses Vasculogenic Mimicry through Inhibiting the Twist/VE-Cadherin/AKT Pathway in Human Prostate Cancer PC-3 Cells.
Topics: Antigens, CD; Cadherins; Catechin; Cell Line, Tumor; Cell Survival; Down-Regulation; Humans; Male; Neoplasm Invasiveness; Neovascularization, Pathologic; Nuclear Proteins; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Signal Transduction; Twist-Related Protein 1 | 2020 |
Epigallocatechin-3-gallate mobilizes intracellular Ca
Topics: Antioxidants; Calcium; Catechin; Cell Survival; Dose-Response Relationship, Drug; Humans; Intracellular Fluid; Male; PC-3 Cells; Prostatic Neoplasms | 2020 |
Multifunctional nanoparticles for targeting the tumor microenvironment to improve synergistic drug combinations and cancer treatment effects.
Topics: Animals; Antineoplastic Agents; Catechin; Docetaxel; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Synergism; Humans; Male; Mice, SCID; Multifunctional Nanoparticles; Prostatic Neoplasms; Tumor Microenvironment | 2020 |
Epigallocatechin-3-gallate Enhances the Efficacy of MicroRNA-34a Mimic and MicroRNA-93 Inhibitor Co-transfection in Prostate Cancer Cell Line.
Topics: Catechin; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Male; MicroRNAs; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Signal Transduction; Transfection | 2020 |
(-)-Epicatechin acts as a potent agonist of the membrane androgen receptor, ZIP9 (SLC39A9), to promote apoptosis of breast and prostate cancer cells.
Topics: Binding, Competitive; Breast Neoplasms; Catechin; Cation Transport Proteins; Female; Humans; Male; Prostatic Neoplasms; Receptors, Androgen; Signal Transduction; Tumor Cells, Cultured | 2021 |
Preparation of Catechin Nanoemulsion from Oolong Tea Leaf Waste and Its Inhibition of Prostate Cancer Cells DU-145 and Tumors in Mice.
Topics: Animals; Antineoplastic Agents; Apoptosis; Caspase 8; Catechin; Cell Cycle; Cell Line, Tumor; Emulsions; Endocytosis; Humans; Inhibitory Concentration 50; Lecithins; Limit of Detection; Male; Mice; Mice, SCID; Nanoparticles; Nanotechnology; Neoplasm Transplantation; Neoplasms, Experimental; Particle Size; Plant Leaves; Polysorbates; Prostatic Neoplasms; Quality Control; Solvents; Tea; Water | 2021 |
Co-Adjuvant Therapy Efficacy of Catechin and Procyanidin B2 with Docetaxel on Hormone-Related Cancers In Vitro.
Topics: Antineoplastic Agents; Biflavonoids; Breast Neoplasms; Catechin; Docetaxel; Drug Screening Assays, Antitumor; Drug Therapy, Combination; Female; Humans; In Vitro Techniques; Male; MCF-7 Cells; Proanthocyanidins; Prostatic Neoplasms | 2021 |
Reduced prostate cancer risk with green tea and epigallocatechin 3-gallate intake among Hong Kong Chinese men.
Topics: Administration, Oral; Aged; Asian People; Case-Control Studies; Catechin; Hong Kong; Humans; Male; Middle Aged; Prostatic Neoplasms; Risk; Tea | 2017 |
Oxidative stress-induced Akt downregulation mediates green tea toxicity towards prostate cancer cells.
Topics: Catechin; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA; Down-Regulation; Humans; Male; Membrane Potential, Mitochondrial; Oxidants; Oxidative Stress; Prostatic Neoplasms; Protein Carbonylation; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Tea | 2017 |
Impact of Green Tea Catechin ECG and Its Synthesized Fluorinated Analogue on Prostate Cancer Cells and Stimulated Immunocompetent Cells.
Topics: Anti-Inflammatory Agents; Antioxidants; Apoptosis; Camellia sinensis; Catechin; Cell Proliferation; Cell Survival; Fluorine; Humans; Inflammation; Lymphocytes; Male; Polyphenols; Prostatic Neoplasms; Tea | 2018 |
Procyanidin from peanut skin induces antiproliferative effect in human prostate carcinoma cells DU145.
Topics: Antineoplastic Agents; Apoptosis; Arachis; bcl-2-Associated X Protein; Biflavonoids; Caspase 3; Catechin; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Chromatography, High Pressure Liquid; Humans; Male; Microscopy, Electron, Transmission; Proanthocyanidins; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Tandem Mass Spectrometry; Tumor Suppressor Protein p53 | 2018 |
Tea's value as a cancer therapy is steeped in uncertainty.
Topics: Animals; Biological Products; Case-Control Studies; Catechin; Cell Line, Tumor; China; Cohort Studies; Dietary Supplements; Disease Models, Animal; Female; Humans; Incidence; Japan; Life Style; Male; Metabolic Syndrome; Mice; Neoplasms; Plant Extracts; Prostatic Neoplasms; Sex Factors; Smoking; Sunitinib; Tea; Uncertainty | 2019 |
[Prostate cancer prevention. the current trends].
Topics: Catechin; Dietary Supplements; Humans; Male; Prostatic Neoplasms; Tea | 2018 |
Differential effect of grape seed extract and its active constituent procyanidin B2 3,3″-di-O-gallate against prostate cancer stem cells.
Topics: Anthocyanins; Antineoplastic Agents, Phytogenic; Apoptosis; Biflavonoids; Catechin; Cell Movement; Cell Proliferation; Cell Survival; Grape Seed Extract; Humans; Jagged-1 Protein; Male; Neoplastic Stem Cells; PC-3 Cells; Proanthocyanidins; Prostate; Prostatic Neoplasms; Receptor, Notch1; Spheroids, Cellular; Tumor Cells, Cultured | 2019 |
Green tea-induced epigenetic reactivation of tissue inhibitor of matrix metalloproteinase-3 suppresses prostate cancer progression through histone-modifying enzymes.
Topics: Acetylation; Antineoplastic Agents; Catechin; Cell Line, Tumor; Cell Movement; DNA Methylation; Enhancer of Zeste Homolog 2 Protein; Histone Code; Histone Deacetylase 1; Histones; Humans; Male; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Plant Preparations; Polyphenols; Promoter Regions, Genetic; Prostatic Neoplasms; Tea; Tissue Inhibitor of Metalloproteinase-3; Transcriptional Activation | 2019 |
Co-Delivery of Natural Compounds with a Dual-Targeted Nanoparticle Delivery System for Improving Synergistic Therapy in an Orthotopic Tumor Model.
Topics: Animals; Catechin; Curcumin; Drug Delivery Systems; Humans; Hyaluronan Receptors; Male; Mice; Mice, SCID; Neoplasm Proteins; Neoplasms, Experimental; P-Selectin; PC-3 Cells; Prostatic Neoplasms; Xenograft Model Antitumor Assays | 2019 |
Epigallocatechin-3-gallate promotes apoptosis and expression of the caspase 9a splice variant in PC3 prostate cancer cells.
Topics: Apoptosis; Caspase 9; Catechin; Cell Line, Tumor; Cisplatin; Gene Expression Regulation, Neoplastic; Humans; Male; Prostatic Neoplasms; Protein Isoforms | 2013 |
Active extracts of black tea (Camellia Sinensis) induce apoptosis of PC-3 prostate cancer cells via mitochondrial dysfunction.
Topics: Adenosine Triphosphate; Apoptosis; Biflavonoids; Camellia sinensis; Caspase 3; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cytochromes c; Humans; Male; Membrane Potential, Mitochondrial; Mitochondria; Necrosis; Polyphenols; Prostatic Neoplasms | 2013 |
Dietary flavonoid intake, black tea consumption, and risk of overall and advanced stage prostate cancer.
Topics: Aged; Antioxidants; Body Mass Index; Catechin; Cohort Studies; Diet; Exercise; Flavonoids; Humans; Incidence; Kaempferols; Male; Middle Aged; Neoplasm Staging; Netherlands; Proportional Hazards Models; Prostate-Specific Antigen; Prostatic Neoplasms; Risk Factors; Socioeconomic Factors; Tea | 2013 |
Syntheses of procyanidin B2 and B3 gallate derivatives using equimolar condensation mediated by Yb(OTf)3 and their antitumor activities.
Topics: Antineoplastic Agents; Biflavonoids; Catechin; Cell Line, Tumor; Gallic Acid; Humans; Male; Mesylates; Organometallic Compounds; Proanthocyanidins; Prostatic Neoplasms | 2013 |
Oral administration of naturally occurring chitosan-based nanoformulated green tea polyphenol EGCG effectively inhibits prostate cancer cell growth in a xenograft model.
Topics: Administration, Oral; Animals; Anticarcinogenic Agents; bcl-2-Associated X Protein; Caspases; Catechin; Cell Proliferation; Chitosan; Enzyme-Linked Immunosorbent Assay; Humans; Immunoblotting; Immunoenzyme Techniques; Male; Mice; Mice, Nude; Nanoparticles; Nanotechnology; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Proliferating Cell Nuclear Antigen; Prostate-Specific Antigen; Prostatic Neoplasms; Tea; Xenograft Model Antitumor Assays | 2014 |
Safety and chemopreventive effect of Polyphenon E in preventing early and metastatic progression of prostate cancer in TRAMP mice.
Topics: Adenocarcinoma; Animals; Catechin; Disease Models, Animal; Disease Progression; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Prostatic Neoplasms; Safety | 2014 |
Synergistic effect of curcumin on epigallocatechin gallate-induced anticancer action in PC3 prostate cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Catechin; Cell Cycle Checkpoints; Cell Division; Cell Line, Tumor; Cell Proliferation; Curcumin; Dose-Response Relationship, Drug; Drug Synergism; Humans; Male; Prostatic Neoplasms; Up-Regulation | 2015 |
Divergent effect of liver X receptor agonists on prostate-specific antigen expression is dependent on androgen receptor in prostate carcinoma cells.
Topics: Benzoates; Benzylamines; Catechin; Cell Line, Tumor; Cell Proliferation; Humans; Hydrocarbons, Fluorinated; Liver X Receptors; Male; Orphan Nuclear Receptors; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Sulfonamides | 2015 |
The heat shock protein 90 inhibitor, (-)-epigallocatechin gallate, has anticancer activity in a novel human prostate cancer progression model.
Topics: Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Catechin; Cell Movement; Cell Proliferation; Disease Progression; HSP90 Heat-Shock Proteins; Humans; Male; Mice; Prostatic Hyperplasia; Prostatic Neoplasms; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured; Wound Healing; Xenograft Model Antitumor Assays | 2015 |
Sensitization to docetaxel in prostate cancer cells by green tea and quercetin.
Topics: Apoptosis; Catechin; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Docetaxel; Down-Regulation; Drug Synergism; Humans; Male; Phosphatidylinositol 3-Kinases; Prostatic Neoplasms; Quercetin; Taxoids; Tea | 2015 |
Development of novel radiochemotherapy approaches targeting prostate tumor progenitor cells using nanohybrids.
Topics: Aldehyde Dehydrogenase; Animals; Antineoplastic Agents; Catechin; Cell Line, Tumor; Cell Proliferation; Chemoradiotherapy; Drug Compounding; Gelatin; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Nanotubes, Carbon; Neoplasm Transplantation; Neoplastic Stem Cells; Prostatic Neoplasms; Radiation-Sensitizing Agents | 2015 |
Epigallocatechin Gallate/Layered Double Hydroxide Nanohybrids: Preparation, Characterization, and In Vitro Anti-Tumor Study.
Topics: Antineoplastic Agents; Catechin; Cell Line, Tumor; Humans; Hydrogen-Ion Concentration; Hydroxides; Male; Nanocomposites; Prostatic Neoplasms | 2015 |
EGCG antagonizes Bortezomib cytotoxicity in prostate cancer cells by an autophagic mechanism.
Topics: Antineoplastic Agents; Autophagy; Bortezomib; Catechin; Cell Line, Tumor; Endoplasmic Reticulum Stress; Eukaryotic Initiation Factor-2; Humans; Leupeptins; Male; Microtubule-Associated Proteins; Prostatic Neoplasms; Proteasome Inhibitors; Transcription Factor CHOP; Up-Regulation | 2015 |
Preparation of catechin extracts and nanoemulsions from green tea leaf waste and their inhibition effect on prostate cancer cell PC-3.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Camellia sinensis; Catechin; Cell Cycle Checkpoints; Cell Line, Tumor; Chromatography, High Pressure Liquid; Emulsions; Humans; Male; Mass Spectrometry; Plant Extracts; Prostatic Neoplasms; Tea | 2016 |
Targeted nanoparticles encapsulating (-)-epigallocatechin-3-gallate for prostate cancer prevention and therapy.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Models, Animal; Drug Carriers; Drug Compounding; Drug Liberation; Humans; Kinetics; Ligands; Male; Mice; Molecular Conformation; Molecular Targeted Therapy; Nanoparticles; Particle Size; Polyesters; Polyethylene Glycols; Prostatic Neoplasms; Tumor Burden; Xenograft Model Antitumor Assays | 2017 |
Green tea catechins suppress the DNA synthesis marker MCM7 in the TRAMP model of prostate cancer.
Topics: Adenocarcinoma; Animals; Biomarkers, Tumor; Catechin; Cell Cycle Proteins; DNA Replication; DNA-Binding Proteins; DNA, Neoplasm; Gene Expression Regulation, Neoplastic; Male; Mice; Mice, Transgenic; Minichromosome Maintenance Complex Component 7; Neoplasms, Experimental; Nuclear Proteins; Prostatic Neoplasms; Tea | 2007 |
Effect of a prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate on the growth of androgen-independent prostate cancer in vivo.
Topics: Acetates; Androgens; Animals; Apoptosis; Biological Availability; Catechin; Cell Division; Humans; Immunohistochemistry; Ki-67 Antigen; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Prodrugs; Proliferating Cell Nuclear Antigen; Prostate-Specific Antigen; Prostatic Neoplasms; Tea; Transplantation, Heterologous | 2008 |
Dihydrotestosterone sensitises LNCaP cells to death induced by epigallocatechin-3-Gallate (EGCG) or an IGF-I receptor inhibitor.
Topics: Blotting, Western; Catechin; Cell Death; Cell Line, Tumor; Dihydrotestosterone; DNA Replication; DNA, Neoplasm; Humans; Male; Neoplasm Proteins; Prostatic Neoplasms; Receptor, IGF Type 1; Thymidine | 2009 |
Suppression of androgen receptor signaling and prostate specific antigen expression by (-)-epigallocatechin-3-gallate in different progression stages of LNCaP prostate cancer cells.
Topics: Animals; Catechin; Cell Line, Tumor; Cell Proliferation; Disease Progression; Humans; Male; Mice; Mice, Inbred BALB C; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Recurrence; Signal Transduction; Transcription, Genetic | 2009 |
[Growth inhibition of prostate cancer cells by epigallocatechin-3-gallate in the presence of Zn2+ in vitro].
Topics: Catechin; Cell Line, Tumor; Cell Movement; Humans; Immunohistochemistry; Male; Matrix Metalloproteinase 9; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Zinc | 2008 |
Mechanism of free Zn(2+) enhancing inhibitory effects of EGCG on the growth of PC-3 cells: interactions with mitochondria.
Topics: Adenosine Triphosphate; Apoptosis; Caspase 9; Catechin; Cell Division; Cell Line, Tumor; Cytochromes c; Drug Synergism; Humans; Male; Membrane Fluidity; Membrane Potential, Mitochondrial; Mitochondria; Prostatic Neoplasms; Zinc | 2009 |
Epigallocatechin-3-gallate affects the growth of LNCaP cells via membrane fluidity and distribution of cellular zinc.
Topics: Catechin; Cell Line, Tumor; Cell Proliferation; Cell Size; Dose-Response Relationship, Drug; Humans; Male; Membrane Fluidity; Prostatic Neoplasms; Zinc | 2009 |
Effect of laminin tyrosine-isoleucine-glycine-serine-arginine peptide on the growth of human prostate cancer (PC-3) cells in vitro.
Topics: Adenosine Triphosphate; Amino Acid Sequence; Androgens; Caspase 9; Catechin; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Humans; Laminin; Male; Membrane Potential, Mitochondrial; Models, Molecular; Molecular Conformation; Oligopeptides; Prostatic Neoplasms; Receptors, Laminin | 2009 |
[Preparation, activity and targeting ability evaluation in vitro on folate mediated epigallocatechin-3-gallate albumin nanoparticles].
Topics: Antineoplastic Agents, Phytogenic; Catechin; Cell Death; Cell Line, Tumor; Drug Carriers; Drug Compounding; Drug Delivery Systems; Folic Acid; Humans; Male; Nanoparticles; Particle Size; Prostatic Neoplasms; Serum Albumin, Bovine | 2009 |
Targeting CWR22Rv1 prostate cancer cell proliferation and gene expression by combinations of the phytochemicals EGCG, genistein and quercetin.
Topics: Antineoplastic Combined Chemotherapy Protocols; Catechin; Cell Growth Processes; Cell Line, Tumor; Culture Media, Serum-Free; Drug Synergism; Gene Expression; Genistein; Humans; Male; Neoplastic Stem Cells; Phytotherapy; Prostatic Neoplasms; Quercetin; Tumor Suppressor Protein p53 | 2009 |
(-)-Epigallocatechin-3-gallate induces Du145 prostate cancer cell death via downregulation of inhibitor of DNA binding 2, a dominant negative helix-loop-helix protein.
Topics: Apoptosis; Catechin; Cell Line, Tumor; Down-Regulation; Humans; Inhibitor of Differentiation Protein 2; Male; Prostatic Neoplasms | 2010 |
Influence of gallate esterification on the activity of procyanidin B2 in androgen-dependent human prostate carcinoma LNCaP cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Biflavonoids; Carcinoma; Caspases; Catechin; Cell Line, Tumor; Cell Survival; Humans; Male; Poly(ADP-ribose) Polymerases; Proanthocyanidins; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Seeds; Vitis | 2010 |
The polyphenol epigallocatechin-3-gallate affects lipid rafts to block activation of the c-Met receptor in prostate cancer cells.
Topics: Anticarcinogenic Agents; Antioxidants; beta-Cyclodextrins; Catechin; Cell Movement; Cells; Flavonoids; Humans; Male; Octoxynol; Phenols; Phosphatidylinositol 3-Kinases; Phosphorylation; Polyphenols; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Signal Transduction; Tea | 2010 |
Regulation of Nrf2- and AP-1-mediated gene expression by epigallocatechin-3-gallate and sulforaphane in prostate of Nrf2-knockout or C57BL/6J mice and PC-3 AP-1 human prostate cancer cells.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Combined Chemotherapy Protocols; Binding Sites; Catechin; Cell Line, Tumor; Cell Survival; Gene Expression Regulation, Neoplastic; Humans; Isothiocyanates; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-E2-Related Factor 2; Promoter Regions, Genetic; Prostatic Neoplasms; Sulfoxides; Thiocyanates; Transcription Factor AP-1 | 2010 |
Gold nanoparticle mediated detection of prostate cancer cells using photoacoustic flowmetry with optical reflectance.
Topics: Acoustics; Catechin; Flow Cytometry; Gold; Humans; Male; Metal Nanoparticles; Neoplastic Cells, Circulating; Prostatic Neoplasms; Signal Processing, Computer-Assisted | 2010 |
Dietary soy and tea mitigate chronic inflammation and prostate cancer via NFκB pathway in the Noble rat model.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; bcl-2-Associated X Protein; Catechin; Chronic Disease; Diet; Disease Models, Animal; Estradiol; Glycine max; I-kappa B Proteins; Inflammation; Interleukin-1beta; Interleukin-6; Isoflavones; Male; NF-kappa B; NF-KappaB Inhibitor alpha; Prostatic Neoplasms; Rats; Signal Transduction; Soy Foods; Tea; Testosterone; Tumor Necrosis Factor-alpha | 2011 |
Procyanidin B3, an inhibitor of histone acetyltransferase, enhances the action of antagonist for prostate cancer cells via inhibition of p300-dependent acetylation of androgen receptor.
Topics: Acetylation; Biflavonoids; Catechin; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Proliferation; E1A-Associated p300 Protein; Histone Acetyltransferases; Humans; Male; Proanthocyanidins; Prostatic Neoplasms; Receptors, Androgen; Transcription, Genetic | 2011 |
Combination therapy with epigallocatechin-3-gallate and doxorubicin in human prostate tumor modeling studies: inhibition of metastatic tumor growth in severe combined immunodeficiency mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Catechin; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Humans; Male; Mice; Mice, Inbred C57BL; Mice, SCID; Neoplasm Metastasis; Prostatic Neoplasms; Tumor Burden; Xenograft Model Antitumor Assays | 2010 |
Green tea polyphenol EGCG blunts androgen receptor function in prostate cancer.
Topics: Androgen Receptor Antagonists; Binding, Competitive; Catechin; Computer Simulation; Fluorescence Resonance Energy Transfer; Humans; Male; MicroRNAs; Prostatic Neoplasms; Receptors, Androgen; Tea; Transcriptional Activation; Tumor Cells, Cultured | 2011 |
Epigallocatechin gallate-loaded polysaccharide nanoparticles for prostate cancer chemoprevention.
Topics: Anticarcinogenic Agents; Apoptosis; Carcinoma; Caspase 3; Catechin; Cell Line; Cell Survival; Chemoprevention; Gum Arabic; Humans; Male; Nanoparticles; Polysaccharides; Prostatic Neoplasms; Tea | 2011 |
Targeted biocompatible nanoparticles for the delivery of (-)-epigallocatechin 3-gallate to prostate cancer cells.
Topics: Anticarcinogenic Agents; Catalytic Domain; Catechin; Cell Line, Tumor; Cell Proliferation; Dipeptides; Drug Carriers; Humans; Kinetics; Male; Molecular Targeted Therapy; Nanoparticles; Polyesters; Prostate-Specific Antigen; Prostatic Neoplasms | 2011 |
Preclinical evaluation of the antitumor activity of bortezomib in combination with vitamin C or with epigallocatechin gallate, a component of green tea.
Topics: Animals; Antineoplastic Agents; Ascorbic Acid; Boronic Acids; Bortezomib; Catechin; Chromatography, Liquid; Drug Screening Assays, Antitumor; Female; Humans; Male; Mice; Mice, SCID; Prostatic Neoplasms; Pyrazines; Tandem Mass Spectrometry; Tea; Xenograft Model Antitumor Assays | 2011 |
Green tea extract (epigallocatechin-3-gallate) reduces efficacy of radiotherapy on prostate cancer cells.
Topics: Antioxidants; Catechin; Humans; Male; Plant Extracts; Prostatic Neoplasms; Tea; Treatment Outcome; Tumor Cells, Cultured | 2011 |
Chronic administration of green tea extract to TRAMP mice induces the collapse of Golgi apparatus in prostate secretory cells and results in alterations of protein post-translational processing.
Topics: Adenocarcinoma; Animals; Catechin; Clusterin; Disease Models, Animal; Endoplasmic Reticulum; Golgi Apparatus; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Prostatic Neoplasms; Protein Processing, Post-Translational; Tea | 2011 |
Shattering the underpinnings of neoplastic architecture in LNCap: synergistic potential of nutraceuticals in dampening PDGFR/EGFR signaling and cellular proliferation.
Topics: Anticarcinogenic Agents; Antineoplastic Agents; Catechin; Cell Line, Tumor; Cell Proliferation; Curcumin; Drug Synergism; ErbB Receptors; Humans; Isothiocyanates; Male; Phosphorylation; Prostatic Neoplasms; Receptor, Platelet-Derived Growth Factor beta; Signal Transduction; Sulfoxides; Thiocyanates | 2011 |
Quercetin increased the antiproliferative activity of green tea polyphenol (-)-epigallocatechin gallate in prostate cancer cells.
Topics: Androgens; Anticarcinogenic Agents; Catechin; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Humans; Male; Methylation; Prostatic Neoplasms; Quercetin; Tea | 2012 |
EGCG suppresses prostate cancer cell growth modulating acetylation of androgen receptor by anti-histone acetyltransferase activity.
Topics: Acetylation; Androgen Receptor Antagonists; Antineoplastic Agents; Apoptosis; Catechin; Cell Line, Tumor; Cell Proliferation; Chemoprevention; Histone Acetyltransferases; Humans; Male; Prostatic Neoplasms; Receptors, Androgen; Transcription, Genetic | 2012 |
Green tea polyphenols increase p53 transcriptional activity and acetylation by suppressing class I histone deacetylases.
Topics: Acetylation; Apoptosis; bcl-2-Associated X Protein; Camellia sinensis; Catechin; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; G1 Phase Cell Cycle Checkpoints; Gene Expression; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Male; Plant Extracts; Polyphenols; Promoter Regions, Genetic; Prostatic Neoplasms; Protein Binding; Protein Processing, Post-Translational; Protein Stability; Transcriptional Activation; Tumor Suppressor Protein p53 | 2012 |
Laminin receptor specific therapeutic gold nanoparticles (198AuNP-EGCg) show efficacy in treating prostate cancer.
Topics: Animals; Anticarcinogenic Agents; Catechin; Cell Line, Tumor; Female; Gold; Gold Radioisotopes; Humans; Male; Metal Nanoparticles; Mice; Mice, SCID; Particle Size; Prostatic Neoplasms; Xenograft Model Antitumor Assays | 2012 |
Protection against oxidative DNA damage and stress in human prostate by glutathione S-transferase P1.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Catechin; Cell Line; Deoxyguanosine; DNA Damage; Enzyme Activation; Epithelial Cells; Gene Expression Regulation, Neoplastic; Glutathione S-Transferase pi; Guanosine Triphosphate; Humans; Hydrogen Peroxide; Male; Oxidative Stress; Prostate; Prostatic Neoplasms; Reactive Oxygen Species | 2014 |
Green tea and prostate cancer.
Topics: Animals; Apoptosis; Catechin; Chemoprevention; Disease Models, Animal; Forecasting; Humans; Male; Mice; Phytotherapy; Prostatic Neoplasms; Receptors, Androgen; Tea | 2002 |
Gene expression profile in human prostate LNCaP cancer cells by (--) epigallocatechin-3-gallate.
Topics: Anticarcinogenic Agents; Catechin; Gene Expression Profiling; Humans; Isoenzymes; Male; Mitogen-Activated Protein Kinases; Oligonucleotide Array Sequence Analysis; Phosphatidylinositol 3-Kinases; Prostatic Neoplasms; Protein Kinase C; Receptor, trkA; Tea | 2002 |
Inhibition of bcl-x(l) phosphorylation by tea polyphenols or epigallocatechin-3-gallate is associated with prostate cancer cell apoptosis.
Topics: Apoptosis; bcl-X Protein; Catechin; Down-Regulation; Flavonoids; Gene Expression; Humans; Male; Mitochondria; Phenols; Phosphorylation; Polymers; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Tea; Tumor Cells, Cultured | 2002 |
Molecular pathway for (-)-epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma; Carrier Proteins; Catechin; Cell Cycle; Cell Cycle Proteins; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinase Inhibitor p18; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Cyclins; Dose-Response Relationship, Drug; Enzyme Inhibitors; G1 Phase; Humans; Intracellular Signaling Peptides and Proteins; Male; Prostatic Neoplasms; Signal Transduction; Tumor Suppressor Proteins | 2003 |
Soy phytochemicals and tea bioactive components synergistically inhibit androgen-sensitive human prostate tumors in mice.
Topics: Androgens; Animals; Catechin; Diet; Drug Synergism; Humans; Male; Mice; Mice, SCID; Prostatic Neoplasms; Soybean Proteins; Tea; Testosterone | 2003 |
Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells.
Topics: Adenocarcinoma; Anticarcinogenic Agents; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspase 8; Caspase 9; Caspases; Catechin; Cell Division; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA, Neoplasm; Enzyme Activation; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Humans; Male; Neoplasm Proteins; NF-kappa B; Nuclear Proteins; Phosphorylation; Poly(ADP-ribose) Polymerases; Prostatic Neoplasms; Protein Processing, Post-Translational; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-mdm2; Signal Transduction; Transcription, Genetic; Tumor Cells, Cultured; Tumor Suppressor Protein p14ARF; Tumor Suppressor Protein p53 | 2003 |
Epigallocatechin-3-gallate is a potent natural inhibitor of fatty acid synthase in intact cells and selectively induces apoptosis in prostate cancer cells.
Topics: Acetic Acid; Antineoplastic Agents; Apoptosis; Catechin; Cell Division; Enzyme Inhibitors; Epithelial Cells; fas Receptor; Fatty Acid Synthases; Fibroblasts; Humans; Male; Prostatic Neoplasms; Tea; Tumor Cells, Cultured | 2003 |
Essential role of caspases in epigallocatechin-3-gallate-mediated inhibition of nuclear factor kappa B and induction of apoptosis.
Topics: Amino Acid Chloromethyl Ketones; Apoptosis; Carcinoma, Squamous Cell; Caspase Inhibitors; Caspases; Catechin; Cell Line, Tumor; Cell Nucleus; Cell Survival; DNA; Dose-Response Relationship, Drug; Enzyme Activation; Humans; Male; Models, Biological; NF-kappa B; Oligopeptides; Poly(ADP-ribose) Polymerases; Prostatic Neoplasms; Protein Structure, Tertiary; Time Factors; Transcription, Genetic | 2004 |
Modulation of phosphatidylinositol-3-kinase/protein kinase B- and mitogen-activated protein kinase-pathways by tea polyphenols in human prostate cancer cells.
Topics: Antineoplastic Agents; Biflavonoids; Catechin; Humans; Male; Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Signal Transduction; Tea; Tumor Cells, Cultured | 2004 |
Growth inhibition of prostate cancer cells by epigallocatechin gallate in the presence of Cu2+.
Topics: Adenoma; Catechin; Cell Division; Cell Survival; Copper; Free Radicals; Humans; Luminescent Measurements; Male; Prostatic Neoplasms; Tumor Cells, Cultured | 2004 |
Theaflavin-3,3'-digallate and penta-O-galloyl-beta-D-glucose inhibit rat liver microsomal 5alpha-reductase activity and the expression of androgen receptor in LNCaP prostate cancer cells.
Topics: Animals; Biflavonoids; Catechin; Cholestenone 5 alpha-Reductase; Gallic Acid; Glucose; Kinetics; Liver; Male; Microsomes, Liver; Prostatic Neoplasms; Rats; Receptors, Androgen; Testosterone | 2004 |
Treatment of epigallocatechin-3-gallate inhibits matrix metalloproteinases-2 and -9 via inhibition of activation of mitogen-activated protein kinases, c-jun and NF-kappaB in human prostate carcinoma DU-145 cells.
Topics: Antineoplastic Agents, Phytogenic; Blotting, Western; Catechin; Cell Line, Tumor; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Fibroblasts; Genes, jun; Humans; JNK Mitogen-Activated Protein Kinases; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; NF-kappa B; Prostatic Neoplasms | 2004 |
The chemopreventive action of catechins in the TRAMP mouse model of prostate carcinogenesis is accompanied by clusterin over-expression.
Topics: Animals; Animals, Genetically Modified; Anticarcinogenic Agents; Catechin; Clusterin; Disease Models, Animal; Gene Expression Regulation; Humans; Male; Mice; Mice, Inbred C57BL; Prostatic Neoplasms; Tea | 2004 |
Prostate carcinoma and green tea: (-)epigallocatechin-3-gallate inhibits inflammation-triggered MMP-2 activation and invasion in murine TRAMP model.
Topics: Adenocarcinoma; Animals; Anticarcinogenic Agents; Catechin; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Inflammation; Male; Matrix Metalloproteinase 2; Mice; Neoplasm Invasiveness; Prostatic Neoplasms; Tea | 2004 |
Prostate carcinoma and green tea: PSA-triggered basement membrane degradation and MMP-2 activation are inhibited by (-)epigallocatechin-3-gallate.
Topics: Antioxidants; Basement Membrane; Carcinoma; Catechin; Gene Expression Regulation, Neoplastic; Humans; Male; Matrix Metalloproteinase 2; Prostate-Specific Antigen; Prostatic Neoplasms; Risk Factors; Tea; Tumor Cells, Cultured | 2004 |
Green tea constituent epigallocatechin-3-gallate selectively inhibits COX-2 without affecting COX-1 expression in human prostate carcinoma cells.
Topics: Antineoplastic Agents; Apoptosis; Arachidonic Acid; Catechin; Cell Division; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprostone; Humans; Isoenzymes; Male; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tea; Tumor Cells, Cultured; Urokinase-Type Plasminogen Activator | 2005 |
Phytoestrogens in common herbs regulate prostate cancer cell growth in vitro.
Topics: Antineoplastic Agents, Hormonal; Catechin; Cell Cycle; Cell Division; Curcumin; DNA Fragmentation; Humans; Male; Phytoestrogens; Prostatic Neoplasms; Quercetin; Receptors, Estrogen; Resveratrol; Stilbenes; Tumor Cells, Cultured | 2004 |
Cytotoxicity of epigallocatechin-3-gallate to LNCaP cells in the presence of Cu2+.
Topics: Anticarcinogenic Agents; Apoptosis; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Copper; Dose-Response Relationship, Drug; Drug Combinations; Humans; Male; Prostatic Neoplasms | 2005 |
Ablation of either p21 or Bax prevents p53-dependent apoptosis induced by green tea polyphenol epigallocatechin-3-gallate.
Topics: Apoptosis; bcl-2-Associated X Protein; Camellia sinensis; Catechin; Cell Division; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; G1 Phase; Humans; Male; Prostatic Neoplasms; RNA, Small Interfering; Transfection; Tumor Suppressor Protein p53 | 2005 |
Growth of LNCaP cells in monoculture and coculture with osteoblasts and response to tNOX inhibitors.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Bone Neoplasms; Capsaicin; Catechin; Cell Survival; Cisplatin; Humans; Isoflavones; Male; Osteoblasts; Paclitaxel; Plant Extracts; Prostatic Neoplasms; Tumor Cells, Cultured | 2005 |
Epigallocatechin gallate inhibits HIF-1alpha degradation in prostate cancer cells.
Topics: Catechin; Cell Line, Tumor; DNA-Binding Proteins; Dose-Response Relationship, Drug; Humans; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Nuclear Proteins; Prostatic Neoplasms; Transcription Factors; Up-Regulation | 2005 |
Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-2'-deoxycytidine.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Carcinoma, Transitional Cell; Catechin; Cell Line, Tumor; Colorectal Neoplasms; Cytidine; Decitabine; Deoxycytidine; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Female; Gene Silencing; HT29 Cells; Humans; Hydralazine; Male; Procainamide; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction | 2005 |
Molecular classification of green tea catechin-sensitive and green tea catechin-resistant prostate cancer in the TRAMP mice model by quantitative real-time PCR gene profiling.
Topics: Animals; Anticarcinogenic Agents; Catechin; Disease Models, Animal; DNA Primers; Gene Expression Profiling; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Prognosis; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Tea | 2006 |
Inhibition of CWR22Rnu1 tumor growth and PSA secretion in athymic nude mice by green and black teas.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; bcl-2-Associated X Protein; Biflavonoids; Catechin; Flavonoids; Male; Mice; Mice, Nude; Phenols; Polyphenols; Prostate-Specific Antigen; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Tea; Up-Regulation | 2006 |
The physiological effect of conventional treatment with epigallocatechin-3-gallate, thymoquinone, and tannic acid on the LNCaP cell line.
Topics: Antineoplastic Agents; Antioxidants; Benzoquinones; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Humans; Male; Prostatic Neoplasms; Tannins; Treatment Outcome | 2006 |
Effects of interactions of EGCG and Cd(2+) on the growth of PC-3 cells and their mechanisms.
Topics: Absorption; Animals; Anticarcinogenic Agents; Cadmium; Catechin; Cell Division; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Interactions; Drug Synergism; Humans; Male; Prostatic Neoplasms; Spectrophotometry, Atomic; Spectrophotometry, Ultraviolet; Tea; Tetrazolium Salts; Thiazoles; Time Factors; Zinc | 2007 |
Evidence of a novel antiapoptotic factor: role of inhibitor of differentiation or DNA binding (Id-1) in anticancer drug-induced apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma, Hepatocellular; Catechin; Cell Line, Tumor; Cell Survival; Cisplatin; Down-Regulation; Doxorubicin; Etoposide; Female; HeLa Cells; Humans; Inhibitor of Differentiation Protein 1; Liver Neoplasms; Male; Mechlorethamine; Methotrexate; Mitomycin; Nasopharyngeal Neoplasms; Paclitaxel; Prostatic Neoplasms; Vincristine | 2007 |
Structure-activity relationships of tea compounds against human cancer cells.
Topics: Anticarcinogenic Agents; Biflavonoids; Breast Neoplasms; Camellia sinensis; Catechin; Cell Death; Cell Line, Tumor; Glutamates; HT29 Cells; Humans; Liver Neoplasms; Male; Plant Leaves; Prostatic Neoplasms; Stomach Neoplasms; Structure-Activity Relationship; Tea | 2007 |
Protein kinase CK2 modulates apoptosis induced by resveratrol and epigallocatechin-3-gallate in prostate cancer cells.
Topics: Apoptosis; Casein Kinase II; Caspase 3; Catechin; Cell Proliferation; Drug Therapy, Combination; Humans; Immunoblotting; Male; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Resveratrol; Signal Transduction; Stilbenes; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured | 2007 |
LNCaP cells exposed to ceramic drug delivery treatment with epigallocatechin-3-gallate, thymoquinone, and tannic acid.
Topics: Anticarcinogenic Agents; Antioxidants; Benzoquinones; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Ceramics; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Combinations; Humans; Male; Neoplasm Proteins; Prostatic Neoplasms; Tannins | 2007 |
Role of Zn2+ in epigallocatechin gallate affecting the growth of PC-3 cells.
Topics: Anticarcinogenic Agents; Catechin; Cell Line, Tumor; Cell Survival; Humans; Male; Prostatic Neoplasms; Tea; Zinc | 2007 |
Theaflavins induced apoptosis of LNCaP cells is mediated through induction of p53, down-regulation of NF-kappa B and mitogen-activated protein kinases pathways.
Topics: Androgens; Antioxidants; Apoptosis; Biflavonoids; Catechin; Cell Line, Tumor; Cell Proliferation; Enzyme Activation; Gene Expression Regulation; Humans; Male; MAP Kinase Signaling System; Necrosis; NF-kappa B; Prostatic Neoplasms; Tumor Suppressor Protein p53 | 2007 |
Anti-tumor effect of ascorbic acid, lysine, proline, arginine, and epigallocatechin gallate on prostate cancer cell lines PC-3, LNCaP, and DU145.
Topics: Antioxidants; Arginine; Ascorbic Acid; Catechin; Cell Line, Tumor; Cell Proliferation; Chemistry, Pharmaceutical; Collagen; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Formazans; Humans; Laminin; Lysine; Male; Matrix Metalloproteinases; Neoplasm Invasiveness; Proline; Prostatic Neoplasms; Proteoglycans; Tetrazolium Salts | 2004 |
Epigallocatechin-3-Gallate suppresses early stage, but not late stage prostate cancer in TRAMP mice: mechanisms of action.
Topics: Adenocarcinoma; Animals; Anticarcinogenic Agents; Apoptosis; Catechin; Cell Proliferation; Drug Screening Assays, Antitumor; Insulin-Like Growth Factor I; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Mice, Transgenic; Prostate; Prostatic Neoplasms; Receptor, IGF Type 1; Receptors, Androgen | 2007 |
Epigallocatechin-3-gallate (EGCG) inhibits PC-3 prostate cancer cell proliferation via MEK-independent ERK1/2 activation.
Topics: Anticarcinogenic Agents; Catechin; Cell Line; Cell Line, Tumor; Cell Proliferation; Chromones; Enzyme Activation; Epithelial Cells; Flavonoids; Humans; Inhibitory Concentration 50; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase Kinases; Morpholines; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Prostatic Neoplasms; Protein Kinase Inhibitors | 2008 |
Theaflavins induce G2/M arrest by modulating expression of p21waf1/cip1, cdc25C and cyclin B in human prostate carcinoma PC-3 cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Biflavonoids; Blotting, Western; Catechin; cdc25 Phosphatases; Cell Cycle; Cell Cycle Proteins; Cell Division; Cell Line, Tumor; Cell Survival; Cyclin B; Cyclin-Dependent Kinase Inhibitor p21; DNA Fragmentation; Flow Cytometry; G2 Phase; Humans; Male; Membrane Potential, Mitochondrial; Prostatic Neoplasms | 2007 |
Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis.
Topics: Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Camellia sinensis; Carcinoma; Catechin; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Resistance, Neoplasm; Drug Synergism; Humans; Male; Neovascularization, Pathologic; Prostatic Neoplasms; TNF-Related Apoptosis-Inducing Ligand | 2008 |
Free Zn(2+) enhances inhibitory effects of EGCG on the growth of PC-3 cells.
Topics: Antioxidants; Catechin; Cell Division; Cell Line, Tumor; Cell Survival; Humans; Male; Prostatic Neoplasms; Protease Inhibitors; Zinc | 2008 |
Protein phosphatase 1 activation and alternative splicing of Bcl-X and Mcl-1 by EGCG + ibuprofen.
Topics: Alternative Splicing; bcl-X Protein; Catechin; Cell Line, Tumor; Drug Synergism; Enzyme Activation; Gene Expression Regulation; Humans; Ibuprofen; Male; Myeloid Cell Leukemia Sequence 1 Protein; Prostatic Neoplasms; Protein Phosphatase 1; Proto-Oncogene Proteins c-bcl-2 | 2008 |
Investigations of the cytotoxicity of epigallocatechin-3-gallate against PC-3 cells in the presence of Cd2+ in vitro.
Topics: Adenosine Triphosphate; Anticarcinogenic Agents; Apoptosis; Cadmium; Caspase 9; Catechin; Cell Line, Tumor; Cell Movement; Cell Survival; Drug Synergism; Humans; Male; Membrane Potential, Mitochondrial; Prostatic Neoplasms; Receptors, Laminin; Tea; Up-Regulation | 2008 |
Cytotoxic effects of digalloyl dimer procyanidins in human cancer cell lines.
Topics: Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Catechin; Cell Line, Tumor; Cell Survival; Central Nervous System Neoplasms; Depsides; Female; Flavonoids; Gallic Acid; Gastrointestinal Neoplasms; Humans; Male; Melanoma; Proanthocyanidins; Prostatic Neoplasms | 2008 |
Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Catechin; Cell Division; Cell Line; Female; Humans; Male; Mice; Mice, Nude; Prostatic Neoplasms; Structure-Activity Relationship; Tea; Time Factors; Transplantation, Heterologous; Tumor Cells, Cultured | 1995 |
Induction of apoptosis in prostate cancer cell lines by the green tea component, (-)-epigallocatechin-3-gallate.
Topics: Antineoplastic Agents; Apoptosis; Catechin; Cell Count; Drug Screening Assays, Antitumor; Flavonoids; Humans; Male; Phenols; Polymers; Prostatic Neoplasms; Tea; Tumor Cells, Cultured | 1998 |
Ingredient in green tea kills prostate cancer cells, study finds.
Topics: Antineoplastic Agents; Catechin; Humans; Male; Prostatic Neoplasms; Tea; Tumor Cells, Cultured | 1999 |
Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (-)-epigallocatechin-3-gallate in androgen-sensitive and androgen-insensitive human prostate carcinoma cells.
Topics: Androgens; Antineoplastic Agents; Apoptosis; Catechin; Cell Cycle; Cell Division; Humans; Male; Prostatic Neoplasms; Tumor Cells, Cultured | 2000 |
Synergistic effects of thearubigin and genistein on human prostate tumor cell (PC-3) growth via cell cycle arrest.
Topics: Anticarcinogenic Agents; Antioxidants; Catechin; Cell Cycle; Cell Division; DNA, Neoplasm; Drug Synergism; Genistein; Humans; Japan; Male; Phenols; Phytotherapy; Polyphenols; Prostatic Neoplasms; Tea; Tumor Cells, Cultured | 2000 |
Tea polyphenols down-regulate the expression of the androgen receptor in LNCaP prostate cancer cells.
Topics: 5' Untranslated Regions; Catechin; Cell Division; Down-Regulation; Flavonoids; Gene Expression Regulation; Humans; Male; Phenols; Polymers; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Regulatory Sequences, Nucleic Acid; Sp1 Transcription Factor; Tea; Tissue Kallikreins; Tumor Cells, Cultured | 2000 |
Detrimental effect of cancer preventive phytochemicals silymarin, genistein and epigallocatechin 3-gallate on epigenetic events in human prostate carcinoma DU145 cells.
Topics: Adaptor Proteins, Signal Transducing; Adaptor Proteins, Vesicular Transport; Anticarcinogenic Agents; Catechin; Cell Cycle; Cell Death; Cell Division; ErbB Receptors; Genistein; Humans; Male; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Plant Extracts; Prostatic Neoplasms; Protein Binding; Proteins; Shc Signaling Adaptor Proteins; Silymarin; Src Homology 2 Domain-Containing, Transforming Protein 1; Transforming Growth Factor alpha | 2001 |
Induction of apoptosis by green tea catechins in human prostate cancer DU145 cells.
Topics: Anticarcinogenic Agents; Apoptosis; Catechin; Cell Division; Humans; Male; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Tea; Tumor Cells, Cultured | 2001 |
Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo.
Topics: Calpain; Caspase 3; Caspases; Catechin; Cell Cycle Proteins; Cell Line, Transformed; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; DNA-Binding Proteins; Esters; Fibroblasts; Flavonoids; Humans; I-kappa B Proteins; Jurkat Cells; Male; Microtubule-Associated Proteins; Models, Molecular; Molecular Conformation; Multienzyme Complexes; NF-KappaB Inhibitor alpha; Phenols; Polymers; Prostatic Neoplasms; Proteasome Endopeptidase Complex; Structure-Activity Relationship; Tea; Tumor Cells, Cultured; Tumor Suppressor Proteins | 2001 |